NCT05831852

Brief Summary

Borderline personality disorder is a mental illness that severely impacts a person's ability to regulate their emotions. This loss of emotional control can increase impulsivity, affect how a person feels about themselves, and negatively impact their relationships with others. In fact, the societal impact of BPDs might be found in emotional suffering, disability and economic burden. In addition in BPD, the suicide rate might be as high as 8-10%. the presence of BPD also interferes with response to treatment of physical and psychiatric comorbidities, such as migraine, HIV, anxiety disorders and substance use disorders. Furthermore, BPD in particular, are associated with high rates of unemployment, absences from work and inefficiency at work, with only 25% of patients suffering from BPD working full time and 40% receiving disability payments. Accordingly, early detection and management would be of great societal and economic impact. Our Study aim is to validate the Arabic version of Maclean Instrument for screening and detection of BPD and and investigate the possible risk factors associated with that disease

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 16, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 26, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

May 1, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

September 7, 2023

Status Verified

September 1, 2023

Enrollment Period

4 months

First QC Date

April 16, 2023

Last Update Submit

September 3, 2023

Conditions

Keywords

BPDMaclean instrumentvalidationrisk factors

Outcome Measures

Primary Outcomes (2)

  • validation of Arabic version of Maclean Instrument

    detection of reliability and consistency

    6 months

  • Detection of Borderline personality disorder Risk factors in Egyptians students

    survey

    6 months

Study Arms (1)

one group

Other: no intervention

Interventions

no intervention

one group

Eligibility Criteria

Age18 Years - 28 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

adults

You may qualify if:

  • age group (18-28 years old )
  • University students

You may not qualify if:

  • less than 18 years old
  • more than 28 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

October University for modern sciences and arts

Giza, Egypt

Location

Related Publications (1)

  • Dias DS, Natividade JC. Brazilian adaptation of the McLean Screening Instrument for Borderline Personality Disorder. Trends Psychiatry Psychother. 2024;46:e20220486. doi: 10.47626/2237-6089-2022-0486. Epub 2022 Oct 18.

MeSH Terms

Conditions

Borderline Personality Disorder

Condition Hierarchy (Ancestors)

Personality DisordersMental Disorders

Study Officials

  • sara Eladawy, PhD

    MSA university

    PRINCIPAL INVESTIGATOR
  • mohamed hafez

    biostatistician, biomedical informatics medical research institute Alexandria University

    STUDY DIRECTOR
  • mohamed emad

    biostatistician, biomedical informatics, medical research institute, Alexandria University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of clinical pharmacy

Study Record Dates

First Submitted

April 16, 2023

First Posted

April 26, 2023

Study Start

May 1, 2023

Primary Completion

September 1, 2023

Study Completion

September 1, 2023

Last Updated

September 7, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations